Fixed formatting of newer files

TODO: Update book locations, idk

src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Bloodstream and Cardiovascular Infections.csv

@@ -19,7 +19,7 @@ E_MI_2.8.1,Enteric Fever (or) Typhoid Fever,"- Classification of Enterobacteriac
 - Pathogenesis
 - Clinical Features
 - Laboratory Diagnosis
-- Management",True,8,2019-02;2014-02;2012-08;2009-08;1998-11;1998-04;1997-10;1992-04,n=MI-apsemm&ed=3&vol=0#302,"A 12 year old female was admitted to the hospital with intense headache, abdominal discomfort for the past 5 days. She had also developed fever which is of **remittent type** with gradual rise in a **step ladder fashion**, On examination, she was toxic with temperature of 101*F, tongue was coated and mild splenomegaly was present.",
+- Management",True,8,2019-02;2014-02;2012-08;2009-08;1998-11;1998-04;1997-10;1992-04,n=MI-apsemm&ed=3&vol=0#302,"A 12 year old female was admitted to the hospital with intense headache, abdominal discomfort for the past 5 days. She had also developed fever which is of **remittent type** with gradual rise in a **step ladder fashion**, On examination, she was toxic with temperature of 101°F, tongue was coated and mild splenomegaly was present.",
 S_MI_2.8.1,Widal Test,,True,4,2018-02;2010-02;2008-08;1993-11,n=MI-apsemm&ed=3&vol=0#306,,
 S_MI_2.8.2,Laboratory Diagnosis of Typhoid/Enteric Fever,,True,3,2022-07;1995-11;1995-04,n=MI-apsemm&ed=3&vol=0#305,,
 S_MI_2.8.3,Drug Resistance in Salmonella typhi,,True,2,2023-02;1996-04,n=MI-apsemm&ed=3&vol=0#308,,

src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Central Nervous System Infections.csv

@@ -32,7 +32,7 @@ S_MI_,Poliomyelitis (or) Polio Virus,- Prophylaxis;- Lab Diagnosis;- Sabin Vacci
 S_MI_,Subacute Sclerosing Panencephalitis,,True,2,2022-02;2019-02,n=MI-apsemm&ed=3&vol=0#724,,
 S_MI_,CSF Analysis,,True,1,2019-08,n=MI-apsemm&ed=3&vol=0#693,,
 S_MI_,Prion Disease,,True,5,2020-11;2020-02;2019-08;2012-02;2010-02,n=MI-apsemm&ed=3&vol=0#725,,
-S_MI_,Japanese B Encephalitis,,True,8,2020-02;2015-08;2009-02;2005-08;2004-08;1998-04;1993-01;1990-10,n=MI-apsemm&ed=3&vol=0#716,,
+S_MI_,Japanese (B) Encephalitis,,True,8,2020-02;2015-08;2009-02;2005-08;2004-08;1998-04;1993-01;1990-10,n=MI-apsemm&ed=3&vol=0#716,,
 S_MI_,Cryptococcal Meningitis (or) Cryptococcosis (or) Cryptococcus neoformans,,True,10,2023-07;2022-02;2018-02;2010-08;2008-08;2004-08;2003-10;1998-04;1997-04;1994-11;1992-04,n=MI-apsemm&ed=3&vol=0#739,,
 E_MI_,Rabies,"- Morphology
 - Pathogenesis

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Environmental and Nutritional Disorders.csv

@@ -2,7 +2,8 @@ Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations
 S_PA_12.2.1,Protein Energy Malnutrition,,True,2,2018-02;2017-02,n=PA-rbpbdsa&ed=10&vol=1#434,,
 S_PA_12.2.1.2,Kwashiorkar,,True,1,1997-04,n=PA-rbpbdsa&ed=10&vol=1#434,"A 4 year old child has presented with **hyperpigmentation**, **desquamation** and **hyperpigmentation of skin**, **puffiness of face** and **enlarged liver**. **Flag sign positive** in hairs.",
 S_PA_12.3,Obesity,,True,2,2022-03;2018-08,n=PA-rbpbdsa&ed=10&vol=1#444,,
-E_PA_12.3,Obesity,"- Pathogenesis
+E_PA_12.3,Obesity,"- Methods of Assessments
+- Etiopathogenesis
 - Complications",True,1,2014-08,n=PA-rbpbdsa&ed=10&vol=1#444,A 12 year old boy has a history of **eating snacks** and **watching television** with **reduced physical activity** for the past few years. **BMI - 30.5**,
 S_PA_12.4,Vitamin D Deficiency (or) Rickets,,True,7,2023-07;2023-02;2020-02;2018-08;2010-08;2008-08;2005-02,n=PA-rbpbdsa&ed=10&vol=1#440,"A 3 year old male child had **frontal bossing**, **pigeon chest** and **bowing of legs**.",
 S_PA_12.5,Vitamin C Deficiency (or) Scurvy,,True,3,2023-02;2019-08;2015-02,n=PA-rbpbdsa&ed=10&vol=1#442,"A 7 yr old child came with complaints of **bleeding gums**, **hemorrhages** and **healing defects**.",

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Genetic disorders.csv

@@ -1,15 +1,19 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-S_PA_11.1.3.4,Turner's Syndrome,,TRUE,7,1991-12;1994-11;1999-04;2003-10;2006-02;2007-02;2012-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.3.4,Klinefelter Syndrome,,TRUE,7,1995-04;1998-11;2008-08;2010-08;2012-08;2017-02;2023-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.3.4,Name 2 disorders involving sex chromosomes,-_Sex_chromatin/-_Klinefelter_syndrome/-_Turner_syndrome/-_Hermaphroditism_and_Pseudoaphroditism,TRUE,4,2017-04;1997-11;2004-08;2020-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.1.3,Marfan Syndrome,,TRUE,1,1997-11,,,
-S_PA_11.1.1.5,Gaucher's disease ,-Stain_used_to_identify,TRUE,6,2000-10;2008-02;2014-02;2014-08;2015-02;2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.3.3,Down Syndrome ( Trisomy 21 ),,TRUE,7,2006-08;2010-02;2016-08;2019-08;2009-02;2013-02;2014-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.1.5,Niemann-Pick Disease,,TRUE,1,2007-08,,,
-S_PA_11.1.3.2,Enumerate 4 types of chromosomal rearrangements,,TRUE,2,2008-08;2019-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.4.2,Mitochondrial inheritance,,TRUE,1,2011-02,,,
-S_PA_11.1.5.3,Hybridisation techniques to detect genomic alterations,-_Fluorescence_In_Situ_Hybridisation,TRUE,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.1.1,Mention four X linked recessive disorders,,TRUE,3,2011-02;2002-03;2018-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.1.5,Glycogen storage disorders,,TRUE,1,2018-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_11.1.1.1,Give 2 example of autosomal recessive disorder,,TRUE,1,2018-08,n=&ed=0&vol=0#0,,
-S_PA_11.1.3.4,Barr body,,TRUE,1,2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.3.4,Turner's Syndrome,,True,7,2012-02;2007-02;2006-02;2003-10;1999-04;1994-11;1991-12,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.3.4,Klinefelter Syndrome,,True,7,2023-02;2017-02;2012-08;2010-08;2008-08;1998-11;1995-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.3.4,Disorders Involving Sex Chromosomes,"- Sex Chromatin
+- Klinefelter Syndrome
+- Turner Syndrome
+- Hermaphroditism
+- Pseudoaphroditism",True,4,2020-08;2017-04;2004-08;1997-11,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.1.3,Marfan Syndrome,,True,1,1997-11,,,
+S_PA_11.1.1.5,Gaucher's Disease,- Stain Used To Identify,True,6,2023-07;2015-02;2014-08;2014-02;2008-02;2000-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.3.3,Down Syndrome (Trisomy 21),,True,7,2019-08;2016-08;2014-08;2013-02;2010-02;2009-02;2006-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.1.5,Niemann-Pick Disease,,True,1,2007-08,,,
+S_PA_11.1.3.2,Types of Chromosomal Rearrangements,,True,2,2019-02;2008-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.4.2,Mitochondrial Inheritance,,True,1,2011-02,,,
+S_PA_11.1.5.3,Hybridisation Techniques To Detect Genomic Alterations,- Fluorescence In Situ Hybridisation,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.1.1,X-Linked Recessive Disorders,,True,3,2018-02;2011-02;2002-03,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.1.5,Glycogen Storage Disorders,,True,1,2018-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_11.1.1.1,Autosomal Recessive Disorders,,True,1,2018-08,n=&ed=0&vol=0#0,,
+S_PA_11.1.3.4,Barr body,,True,1,2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Immunology.csv

@@ -1,25 +1,33 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-S_PA_9.2.5,Cell mediated (Type 4) Hypersensitivity reaction,,TRUE,2,1991-12;2023-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.5,L.E (Lupus Erythematosus) phenomenon,,TRUE,3,1992-04;2008-02;2015-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.3,Phagocytosis,,TRUE,5,1992-04;1999-04;2005-08;2010-02;2014-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.1.3,Cytokines,,TRUE,3,1994-11;2001-04;2020-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-E_PA_9.6,AIDS (Acquired immunodeficiency syndrome),-_Etiology/-_Routes_of_transmission/-_Pathogenesis/-_Clinical_features/-_Major_and_minor_signs/-_Laboratory_diagnosis/-_Opportunistic_infections,TRUE,9,1994-11;2007-08;2010-02;2011-02;2012-02;2014-02;2016-08;2020-02;2023-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-E_PA_3.1;3.2,Amyloidosis,-_Pathogenesis/-_Primary_amyloidosis/-_Stains_used_and_staining_characteristics/-_Effect_on_various_organs,TRUE,10,1995-04;2000-04;2004-08;2005-08;2008-02;2009-08;2010-02;2011-02;2012-08;2013-08;2014-08;2015-08;2020-11;2020-08;2022-08;2022-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.3,Antibody mediated (Type 2) Hypersensitivity,,TRUE,3,1995-11;2002-03;2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.6.1,Classify primary immunodeficiency syndromes and describe in more details,,TRUE,1,2000-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.3.2,Morphology of transplant rejection reactions,,TRUE,4,2000-10;2021-02;2021-09;2022-08,n=PA-rbpbdsa&ed=101&vol=1#0,,
-S_PA_9.1.1,Natural killer cells,,TRUE,1,2001-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.3,Histocompatibilty complex,,TRUE,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
-"S_PA_3,1;3.2",Anti nuclear antibodies,,TRUE,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.1.4,T-Lymphocyte,,TRUE,1,2004-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-E_PA_9.2.4,Classify hypersensitivity reactions. Describe in detail Immune complex (Type 3) Hypersensitivity reaction,,TRUE,5,2009-02;2012-02;2017-08;2022-02;2023-02,n=PA-rbpbdsa&ed=101&vol=1#0,,
-S_PA_9.2.2,Mast cells,,TRUE,1,2009-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.4,Mechanism of autoimmune disease.,-_Name_4_autoimmune_diseases,TRUE,3,2009-08;2018-02;2023-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.2,Anaphylaxis ,,TRUE,3,2010-02;2013-02;2022-03,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.2,Type 1 (Immediate) Hypersensitivity reaction,,TRUE,4,2010-08;2019-02;2020-08;2020-11,n=PA-rbpbdsa&ed=101&vol=1#0,,
-S_PA_9.5,Mention 2 renal changes in SLE,,TRUE,3,2011-02;2014-08;2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.6.1,Hyper IGM Syndrome,,TRUE,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.4,Arthus reaction,,TRUE,2,2012-08;2015-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.2.3,Type 2 Hypersensitivity reaction,,TRUE,2,2014-02;2018-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-S_PA_9.3.3,Graft vs Host disease,,TRUE,1,2019-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
-E_PA_9.5,Systemic Lupus Erythematosus,,TRUE,1,2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.5,Cell Mediated (Type 4) Hypersensitivity Reaction,,True,2,2023-02;1991-12,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.5,Lupus Erythematosus (LE) Phenomenon,,True,3,2015-08;2008-02;1992-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.3,Phagocytosis,,True,5,2014-02;2010-02;2005-08;1999-04;1992-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.1.3,Cytokines,,True,3,2020-02;2001-04;1994-11,n=PA-rbpbdsa&ed=10&vol=1#0,,
+E_PA_9.6,Acquired Immunodeficiency Syndrome (AIDS),"- Etiology
+- Routes of Transmission
+- Pathogenesis
+- Clinical Features
+- Major and Minor Signs
+- Laboratory Diagnosis
+- Opportunistic Infections",True,9,2023-02;2020-02;2016-08;2014-02;2012-02;2011-02;2010-02;2007-08;1994-11,n=PA-rbpbdsa&ed=10&vol=1#0,,
+E_PA_3.1;3.2,Amyloidosis,"- Pathogenesis
+- Primary Amyloidosis
+- Stains Used And Staining Characteristics
+- Effect On Various Organs",True,10,2022-08;2022-08;2020-11;2020-08;2015-08;2014-08;2013-08;2012-08;2011-02;2010-02;2009-08;2008-02;2005-08;2004-08;2000-04;1995-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.3,Antibody Mediated (Type 2) Hypersensitivity,,True,5,2018-08;2014-02;2011-02;2002-03;1995-11,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.6.1,Primary Immunodeficiency Syndromes,,True,1,2000-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.3.2,Morphology of Transplant Rejection Reactions,,True,4,2022-08;2021-09;2021-02;2000-10,n=PA-rbpbdsa&ed=101&vol=1#0,,
+S_PA_9.1.1,Natural Killer (NK) cells,,True,1,2001-04,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.3,Histocompatibilty Complex,,True,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_3.1;3.2,Anti-Nuclear Antibodies,,True,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.1.4,T-Lymphocyte,,True,1,2004-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+E_PA_9.2.4,Hypersensitivity Reactions,- Immune complex (Type 3) Hypersensitivity reaction,True,5,2023-02;2022-02;2017-08;2012-02;2009-02,n=PA-rbpbdsa&ed=101&vol=1#0,,
+S_PA_9.2.2,Mast Cells,,True,1,2009-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.4,Mechanism of Autoimmune Diseases,,True,3,2023-02;2018-02;2009-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.2,Anaphylaxis,,True,3,2022-03;2013-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.2,Type 1 (Immediate) Hypersensitivity reaction,,True,4,2020-11;2020-08;2019-02;2010-08,n=PA-rbpbdsa&ed=101&vol=1#0,,
+S_PA_9.5,Renal Changes in SLE,,True,3,2023-07;2014-08;2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.6.1,Hyper IgM Syndrome,,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.2.4,Arthus reaction,,True,2,2015-02;2012-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+S_PA_9.3.3,Graft vs Host Disease,,True,1,2019-08,n=PA-rbpbdsa&ed=10&vol=1#0,,
+E_PA_9.5,Systemic Lupus Erythematosus (SLE),,True,1,2023-07,n=PA-rbpbdsa&ed=10&vol=1#0,,

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Infectious Diseases.csv

@@ -1,10 +1,10 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-S_PA_10.1,Malaria or Black Water Fever,,True,2,2023-02;2012-02,,,
+S_PA_10.1,Malaria (or) Black Water Fever,,True,2,2023-02;2012-02,,,
 S_PA_10.2,Cysticercosis,,True,1,2018-02,,,
-S_PA_10.3,Leprosy,,True,4,2009-08;2010-02;2012-08;2014-02,,,
+S_PA_10.3,Leprosy,,True,4,2014-02;2012-08;2010-02;2009-08,,,
 S_PA_10.4,Dengue,,True,2,2020-02;2018-08,,,
-S_PA_10.5,Mucormycosis,,True,2,2021-09;2022-02,,,
-S_PA_10.6,Actinomycosis or Mycetoma Foot,,True,3,2018-08;2009-02;2010-02,,,
+S_PA_10.5,Mucormycosis,,True,2,2022-02;2021-09,,,
+S_PA_10.6,Actinomycosis (or) Mycetoma Foot,,True,3,2018-08;2010-02;2009-02,,,
 S_PA_10.7,Viral Hemorrhagic Fever,,True,1,2012-02,,,
-S_PA_10.8,Tuberculosis,- Primary Pulmonary Tuberculosis ;- Miliary Tuberculosis;- Extra-Pulmonary Tuberculosis,True,5,2012-08;2022-03;2023-07;1995-04;2019-08,,"A 10 Year old male with **evening rise of temperature**, neck nodes. His father was treated for **cough with expectoration for 6 months**.",
+S_PA_10.8,Tuberculosis,- Primary Pulmonary Tuberculosis;- Miliary Tuberculosis;- Extra-Pulmonary Tuberculosis,True,5,2023-07;2022-03;2019-08;2012-08;1995-04,,"A 10 year old male with **evening rise of temperature, neck nodes**. His father was treated for **cough with expectoration for 6 months**.",
 S_PA_10.8,Tertiary Syphilis,,True,1,2013-02,,,

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Blood Vessels.csv

@@ -1,12 +1,12 @@
-Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-E_PA_27.1.2,Atherosclerosis,"- Define
-- risk factors
-- pathogenesis
+Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
+E_PA_27.1.2,Atherosclerosis,"- Definition
+- Risk Factors
+- Pathogenesis
 - Morphology
--complication",True,8,2019-08;2014-02;2007-02;2005-02;2003-10;2002-03;1997-10;2023-04,n=PA-rbpbdsa&ed=10&vol=1#493,,
-S_PA_27.1.2,Atherosclerosis,,True,2,2018-08;2023-07,n=PA-rbpbdsa&ed=10&vol=1#493,,
-S_PA_27.1.2,Atherosclerotic plaque,,True,4,2021-09;2016-02;2010-08;2004-08,n=PA-rbpbdsa&ed=10&vol=1#493,,
-S_PA_27.1.2,Consequences of atherosclerosis,,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#493,,
+- Complications",True,8,2023-04;2019-08;2014-02;2007-02;2005-02;2003-10;2002-03;1997-10,n=PA-rbpbdsa&ed=10&vol=1#493,,
+S_PA_27.1.2,Atherosclerosis,,True,2,2023-07;2018-08,n=PA-rbpbdsa&ed=10&vol=1#493,,
+S_PA_27.1.2,Atherosclerotic Plaque,,True,4,2021-09;2016-02;2010-08;2004-08,n=PA-rbpbdsa&ed=10&vol=1#493,,
+S_PA_27.1.2,Consequences of Atherosclerosis,,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#493,,
 S_PA_27.2,Aneurysm,,True,4,2019-02;2017-08;2010-08;1998-04,n=PA-rbpbdsa&ed=10&vol=1#504,,
-S_PA_27.11,Pathogenesis of hypertension,,True,1,2015-02,n=PA-rbpbdsa&ed=10&vol=1#489,,
-S_PA_27.2,Dissecting aneurysm,,True,1,1995-02,n=PA-rbpbdsa&ed=10&vol=1#507,,
+S_PA_27.11,Pathogenesis of Hypertension,,True,1,2015-02,n=PA-rbpbdsa&ed=10&vol=1#489,,
+S_PA_27.2,Dissecting Aneurysm,,True,1,1995-02,n=PA-rbpbdsa&ed=10&vol=1#507,,

src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Bones, Joints and Soft Tissue Tumors.csv

@@ -1,22 +1,21 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-S_PA_33.1,Osteomyelitis,-Acute Osteomyelitis;-Chronic Osteomyelitis,True,4,2022-08;2011-08;2004-08;2006-08,n=PA-rbpbdsa&ed=10&vol=2#1185;n=PA-ramd&ed=4&vol=1#836,,
+S_PA_33.1,Osteomyelitis,- Acute Osteomyelitis;- Chronic Osteomyelitis,True,4,2022-08;2011-08;2006-08;2004-08,n=PA-rbpbdsa&ed=10&vol=2#1185;n=PA-ramd&ed=4&vol=1#836,,
 S_PA_33.1.1,Pyogenic Osteomyelitis,,True,1,2010-08,n=PA-rbpbdsa&ed=10&vol=2#0;n=PA-ramd&ed=4&vol=1#0,,
-S_PA_33.1.2,Mycobacterial Or Tuberculous Osteomyelitis,,True,1,1995-08,n=PA-rbpbdsa&ed=10&vol=2#1186;n=PA-ramd&ed=4&vol=2#839,,
-S_PA_33.2,Bone Tumors,-Classification;-Etiopathogenesis and Pathology of Osteogenic Sarcoma;-Genetic Alterations and Morphology of Osteosarcoma;-Radiological Findings in Various Bone Tumors,True,2,2020-11;2023-02,n=&ed=10&vol=2#1187;n=PA-ramd&ed=4&vol=1#841,A 15 year old male presented with lytic lesion lower end of femur. X-Ray revealed Codman’s triangle and sun ray appearance.,
-S_PA_33.2.1,Osteosarcoma or Osteogenic Sarcoma,,True,7,2020-02;2009-08;2003-10;2007-08;1991-12;1998-10;2000-10,n=PA-rbpbdsa&ed=10&vol=2#0;n=PA-ramd&ed=4&vol=1#0,"A 15 year old male presented with lytic lesion lower end of femur. X-Ray revealed codman’s triangle and sun ray appearance. ",
-S_PA_33.2.2,Osteoclastoma (or) Giant Cell Tumor,,True,5,2017-02;2008-08;2002-03;2012-02;2023-12,,A 30 year old female with **lytic lesion** in distal ulna and X-ray revealed **soap bubble appearance**.,
-S_PA_33.2.3,Ewing Sarcoma,,True,6,2022-08;2014-02;2001-04;1995-11;1997-10;2023-12,,,
+S_PA_33.1.2,Mycobacterial (or) Tuberculous Osteomyelitis,,True,1,1995-08,n=PA-rbpbdsa&ed=10&vol=2#1186;n=PA-ramd&ed=4&vol=2#839,,
+E_PA_33.2,Bone Tumors,- Classification;- Etiopathogenesis and Pathology of Osteogenic Sarcoma;- Genetic Alterations and Morphology of Osteosarcoma;- Radiological Findings in Various Bone Tumors,True,2,2023-02;2020-11,n=&ed=10&vol=2#1187;n=PA-ramd&ed=4&vol=1#841,A 15 year old male presented with **lytic lesion lower end of femur**. X-Ray revealed **Codman’s triangle and sun ray appearance.**,
+S_PA_33.2.1,Osteosarcoma (or) Osteogenic Sarcoma,,True,7,2020-02;2009-08;2007-08;2003-10;2000-10;1998-10;1991-12,n=PA-rbpbdsa&ed=10&vol=2#0;n=PA-ramd&ed=4&vol=1#0,A 15 year old male presented with **lytic lesion lower end of femur**. X-Ray revealed **Codman’s triangle and sun ray appearance.**,
+S_PA_33.2.2,Osteoclastoma (or) Giant Cell Tumor,,True,5,2023-12;2017-02;2012-02;2008-08;2002-03,,A 30 year old female with **lytic lesion** in distal ulna and X-ray revealed **soap bubble appearance**.,
+S_PA_33.2.3,Ewing Sarcoma,,True,6,2023-12;2022-08;2014-02;2001-04;1997-10;1995-11,,,
 S_PA_33.2.4,Osteochondroma,,True,2,2023-07;2013-02,,,
-S_PA_33.2.5,Chondroblastoma,,True,4,2011-08;2014-08;2002-03;2003-10,,,
-S_PA_33.2.6,Cartilage Forming or Chondrogenic Tumors,,True,4,2009-08;2023-02;2010-08;2015-02,,,
-S_PA_33.3.1,"Rhabdomyosarcoma
-",,True,3,2022-02;2014-08;1997-10,,,
+S_PA_33.2.5,Chondroblastoma,,True,4,2014-08;2011-08;2003-10;2002-03,,,
+S_PA_33.2.6,Cartilage Forming (or) Chondrogenic Tumors,,True,4,2023-02;2015-02;2010-08;2009-08,,,
+S_PA_33.3.1,Rhabdomyosarcoma,,True,3,2022-02;2014-08;1997-10,,,
 S_PA_33.3.2,Leiomyoma,,True,1,2008-08,,,
 S_PA_33.3.3,Liposarcoma,,True,1,2011-02,,,
 S_PA_33.3.4,Lipoma,,False,1,,,,
-S_PA_33.4,Paget Disease of Bone,,True,3,2008-02;2011-02;2008-02,,,
+S_PA_33.4,Paget Disease of Bone,,True,3,2011-02;2008-02;2008-02,,,
 S_PA_33.5,Rheumatoid Arthritis,,True,1,2022-02,,,
-S_PA_33.6,"Osteonecrosis ",,True,1,2011-02,,,
-S_PA_33.7,Gout,,True,4,2019-02;2009-08;2018-08;2016-02,,,
+S_PA_33.6,Osteonecrosis,,True,1,2011-02,,,
+S_PA_33.7,Gout,,True,4,2019-02;2018-08;2016-02;2009-08,,,
 S_PA_33.7,Adamantinoma Jaw,,True,1,2014-08,,,
-S_PA_,Fracture Healing,,True,2,2012-08;2013-08,,,
+S_PA_,Fracture Healing,,True,2,2013-08;2012-08,,,